VRValerie Rico

Valerie Rico

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valerie Rico has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Building on existing literature towards person centered language

    by Helen Webster, Megan Zelinsky, Valerie Rico, Kathryn Martinez, Lauren Sankary

  • Reconciling recommendations for ethical sharing of biomarker results with Alzheimer's disease research participants: A systematic review and qualitative synthesis

    by Helen Webster, Megan Zelinsky, Valerie Rico, Kathryn Martinez, Lauren Sankary

    Background: The shift toward a biological definition of Alzheimer's disease (AD) has led to increased use of biomarkers (e.g., amyloid, tau, APOE genotype) in research settings. As return of biomarker results becomes more common in AD research, understanding how participants perceive and make decisions about receiving individual research results is essential for ethical trial design and informed consent practices. Objective: (1) To map and appraise the landscape of qualitative and mixed-methods research focused on perspectives of AD research community members related to biomarker result sharing in AD research settings; and (2) to synthesize findings on decisional needs of research participants considering whether to receive individual biomarker or genetic risk information. Methods: We searched PubMed and EMBASE for qualitative and mixed-methods studies published between January 2012 and January 2025. Eligibility criteria included empirical studies reporting qualitative data on experiences, attitudes, or decision-making processes related to receiving AD biomarker or genetic results in research contexts. Results: Of 3269 records screened, 42 records were assessed for eligibility and 8 met inclusion criteria and were included in our final analysis. Participants emphasized empowerment through research participation and desire for knowledge related to research results. Across studies, decisional needs, characterized as “aspects of decision-making” clustered around four domains: (1) clarity of biomarker meaning and limitations, (2) emotional readiness and support, (3) social consequences of disclosure, and (4) alignment with personal values and future planning. Conclusions: Findings can inform the development of ethically grounded protocols for returning individual research results in preclinical AD trials.


  • Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus

    by Valerie Rico, Megan Zelinsky, Paul J Ford, James Leverenz, Jagan A Pillai, Justin B Miller, Kathryn Martinez, Alan J Lerner, Babak Tousi, Liana G Apostolova, et al.

    Background: As criteria for diagnosing Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) evolves, AD-related biological measures of biomarkers (e.g., amyloid, tau) and genetic status (e.g., APOE ) have gained heightened value in research, and, notably, increased personal significance for participants. Objective: To identify recommended approaches for sharing individual research results with participants in AD/ADRD research and determine expert consensus on best practices for sharing individual research results to participants in AD/ADRD research. Methods: This online, modified Delphi study consisted of four rounds of surveys conducted with Alzheimer's disease research experts, including neurologists, ethicists, neuropsychologists, geneticists, clinical trialists, and other research stakeholders. The Delphi survey was informed by a targeted literature review of previously published recommendations on sharing individual research results in AD/ADRD research. A total of 81 experts were surveyed across all rounds, ranking statements on a 7-point Likert scale and providing feedback in short answer responses. After each round, feedback reports were shared to inform subsequent responses. Proportion of agreement and qualitative feedback were analyzed, with consensus defined as 75% or greater agreement. Results: 41 initial statements were evaluated and refined based on consensus and feedback. Concluding the final round (round 3), consensus (≥75% agreement) was achieved on 25 statements, resulting in a set of recommendations related to: study design, clinical relevance, results sharing processes, communication and understanding of results, counseling and support, and follow-up. Conclusions: The findings of this online, modified Delphi study provide a foundation for developing standardized, ethically grounded practices for returning individual research results in Alzheimer's disease studies.